118 related articles for article (PubMed ID: 7379053)
1. Tamoxifen in metastatic malignant melanoma.
Meyskens FL; Voakes JB
Cancer Treat Rep; 1980 Jan; 64(1):171-3. PubMed ID: 7379053
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
Tan EH; Ang PT
Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of tamoxifen in patients with metastatic malignant melanoma.
Telhaug R; Klepp O; Børmer O
Cancer Treat Rep; 1982 Jun; 66(6):1437. PubMed ID: 7083247
[No Abstract] [Full Text] [Related]
4. Lomustine, vincristine, and procarbazine in the treatment of metastatic malignant melanoma.
Shelley W; Quirt I; Bodurtha A; Iscoe N; Russell J; Paterson A; Young V
Cancer Treat Rep; 1985 Sep; 69(9):941-4. PubMed ID: 2992784
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen in the treatment of metastatic malignant melanoma.
Wagstaff J; Thatcher N; Rankin E; Crowther D
Cancer Treat Rep; 1982 Sep; 66(9):1771. PubMed ID: 7116353
[No Abstract] [Full Text] [Related]
6. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
8. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of tamoxifen in malignant melanoma.
Leichman CG; Samson MK; Baker LH
Cancer Treat Rep; 1982 Jun; 66(6):1447. PubMed ID: 7083248
[No Abstract] [Full Text] [Related]
11. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma.
Eisen T; Thomas J; Miller WH; Gore M; Wolter P; Kavan P; Martín JA; Lardelli P
Melanoma Res; 2009 Jun; 19(3):185-92. PubMed ID: 19436178
[TBL] [Abstract][Full Text] [Related]
12. [Role of an anti-estrogen, tamoxifen, in the treatment of metastatic malignant melanoma].
Quencez E; Blanc D; Adessi G; Agache P; Laurent R
Ann Dermatol Venereol; 1985; 112(4):341-6, 349. PubMed ID: 4026132
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
Berman E; Casper ES; Howard J; Wittes RE
Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
[TBL] [Abstract][Full Text] [Related]
14. A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazine.
Saunders MP; Salisbury AJ; O'Byrne KJ; Souliotis VL; Varcoe SM; Talbot DC; Kyrtopoulos SA; Harris AL
Anticancer Res; 1997; 17(6D):4677-80. PubMed ID: 9494588
[TBL] [Abstract][Full Text] [Related]
15. A pilot study with vincristine sulfate liposome infusion in patients with metastatic melanoma.
Bedikian AY; Papadopoulos NE; Kim KB; Vardeleon A; Smith T; Lu B; Deitcher SR
Melanoma Res; 2008 Dec; 18(6):400-4. PubMed ID: 19011511
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of the dopaminergic inhibitor pimozide in previously treated melanoma patients.
Neifeld JP; Tormey DC; Baker MA; Meyskens FL; Taub RN
Cancer Treat Rep; 1983 Feb; 67(2):155-7. PubMed ID: 6825122
[TBL] [Abstract][Full Text] [Related]
17. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
Agarwala SS; Ferri W; Gooding W; Kirkwood JM
Cancer; 1999 May; 85(9):1979-84. PubMed ID: 10223239
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of tamoxifen in patients with disseminated malignant melanoma.
Creagan ET; Ingle JN; Green SJ; Ahmann DL; Jiang NS
Cancer Treat Rep; 1980; 64(2-3):199-201. PubMed ID: 7407752
[TBL] [Abstract][Full Text] [Related]
19. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
20. Single-institution outcome of high-dose interleukin-2 (HD IL-2) therapy for metastatic melanoma and analysis of favorable response in brain metastases.
Powell S; Dudek AZ
Anticancer Res; 2009 Oct; 29(10):4189-93. PubMed ID: 19846971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
